Lactic Peel

L80

Step-by-step clinical application guide for practitioners

Depth
Superficial to Medium
Contact
3–5 min
Neutralize
Requires neutralization
Fitzpatrick
I–IV (caution V)
Sessions
4–6
Downtime
1–3 days (mild)

Overview

Step-by-step clinical application guide for practitioners

01

Safety

Critical
THIS PEEL REQUIRES NEUTRALIZATION. prodermic L80 is NOT self-neutralizing. Practitioner MUST neutralize in-clinic after 3–5 minutes. At this concentration, timing is critical.

Contraindications

  • Active skin infections in treatment area
  • Compromised skin barrier
  • Pregnancy or breastfeeding
  • Isotretinoin use within the last 6 months
  • Topical retinoids use within 72 hours
  • Open wounds or broken skin in treatment area
  • Fitzpatrick V skin type (extreme caution only)
  • Known allergy to lactic acid

Neutralize Immediately If

  1. Severe burning or pain
  2. Intense erythema (deep red)
  3. Visible edema or swelling
  4. Urticaria (hives or welts)
  5. Patient distress or inability to tolerate

Stop the procedure and neutralize with cold water or sodium bicarbonate.

02

Composition

IngredientConcentrationRole
Lactic AcidUltra-high concentration AHA. Disrupts corneocyte cohesion for controlled exfoliation. Uniquely hydrating among AHAs. Increases ceramide synthesis. Mild tyrosinase inhibition for brightening.
03

Indications

Fitzpatrick I–IV (caution V)
  • Anti-Aging
  • Hydration
  • Brightening
  • Sensitive Skin
04

Procedure

  1. 01

    Cleanse & Degrease

    2–3 min

    Cleanse with gentle non-residue cleanser. Remove makeup, sunscreen, surface impurities. Degrease skin using pre-peel degreasing solution with gauze.

    • Degreasing contact: 1–2 minutes. Wipe clean. Allow skin to dry for 30 seconds.
  2. 02

    Patch Test

    2 min

    Apply a small amount behind the ear. Observe for 2 minutes for any adverse reaction.

    • Shorter patch test duration (2 min) due to high concentration. If any reaction, do not proceed.
  3. 03

    Apply prodermic L80

    1–2 min

    Apply 1–1.5ml of product. The formulation is a liquid/gel consistency. START TIMER IMMEDIATELY upon application. Apply in thin, even layers using fan brush.

    • START TIMER IMMEDIATELY. Timing is critical at this concentration.
  4. 04

    Monitor & Titrate

    3–5 min

    Monitor continuously for 3–5 minutes. NEVER exceed 5 minutes contact time. First session target is 2 minutes. Watch for uniform pink erythema.

    • NEVER exceed 5 minutes. First session: 2 min target. Increase progressively in subsequent sessions.
  5. 05

    Neutralize

    2–3 min

    Apply sodium bicarbonate solution or cold water to neutralize the peel. Gently wipe with damp gauze until all product is removed.

    • This peel is NOT self-neutralizing. Neutralize thoroughly in-clinic. Do not allow patient to leave with product on.
  6. 06

    Post-Peel Soothing & Discharge

    3–5 min

    Apply recovery moisturizer and SPF 50+ sunscreen. Skin should feel hydrated post-treatment. Provide written post-care instructions.

    • Skin typically feels hydrated rather than tight immediately post-peel due to lactic acid’s humectant properties.
05

Post-procedure

Daily regimen
Day 0Peel Day Neutralized in-clinic. Skin feels hydrated. Recovery moisturizer applied. No actives/makeup rest of day.
Day 0–1Mild Tightness Mild tightness possible. Gentle cleanser 2x daily. Thick moisturizer. SPF 50+.
Day 1–2Very Mild Flaking Very mild flaking may occur. Some patients may not peel visibly. Continue moisturizer + SPF 50+.
Day 2–3Smoother & Brighter Skin appears smoother, brighter, and more hydrated. Resume light makeup if desired.
Days 3–14Between Sessions Strict sun protection. Resume normal skincare. Next session in 14–21 days.
06

Session plan

Sessions
4–6
Interval
14–21 days
Downtime
1–3 days (mild)
Total
2–3 months
Progressive dose schedule
SessionContact time
Session 12 min
Session 23 min
Session 33–4 min
Session 4+4–5 min (max — never exceed 5 min)
07

Expected results

Clinical outcomes from supervised sessions. Actual results depend on skin type, adherence to protocol, and sun protection.

Case 01
Case 02